We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clinical Investigator Cited for Confining Patient
Clinical Investigator Cited for Confining Patient
September 5, 2007
The FDA cited David Linden, the principal investigator for Oklahoma-based Linden Research Consultants (LRC), for not allowing a patient to leave the inpatient psychiatric research facility and discontinue her participation in a bipolar disorder clinical trial, according to an agency warning letter.